Skip to main content
. 2022 May 24;151(10):1804–1809. doi: 10.1002/ijc.34054

FIGURE 1.

FIGURE 1

Age‐standardized incidence per 100 000 women over time for a noninferior single dose human papillomavirus (HPV) vaccination program implemented in 2021 or delayed to 2026 for the Harvard (A) and HPV‐ADVISE (B) simulation models. Cases averted are compared to a noninferior single‐dose vaccination program implemented in 2026 and are estimated for a starting cohort of 1 million women alive in 2021 over years 2021 to 2120 (inclusive). [Color figure can be viewed at wileyonlinelibrary.com]